---
$id: https://graph.org.ai/products/commodity/51282936
$type: Product
source: UNSPSC
code: "51282936"
title: "Pazufloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pazufloxacin

**UNSPSC Code**: 51282936
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C16H15FN2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4CZ1R38NDI, chemically known as 7h-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-, (s)- but generally known as pazufloxacin, which bears US NIH Compound Identifier 65957. European Medicines Agency schedules Pazufloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09641MIG. The term PAZUFLOXACIN is an International Non-Proprietary Name. World Health Organization schedules pazufloxacin in its Anatomical Therapeutic Chemical (ATC) Classification. PAZUFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pazufloxacin under HS 29349990 and SITC 51579. As of Q4 2014, PAZUFLOXACIN remains the US FDA Preferred Term for this commodity. Pazufloxacin bears US NLM identifiers UMLS ID C0175022 and NCI Concept Code C66331. SMILES: FC1C(C2(N)CC2)C2OCC(N3C2C(C1)C(=O)C(C3)C(=O)O)C.

